Valuation
- Market cap
- 42,048,000
- Revenue TTM
- $12,800,000
- Net income TTM
- $-11,700,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -91.41%
- Debt to equity
- 0.45
Trading
- Volume
- 100,500
- Avg volume
- 71,264
- Day's range
- $10.56 – $11.80
- Shares out
- 3,563,000
- Stochastic %K
- 71%
- Beta
- 0.86
- Analysts
- Moderate Buy
- Price target
- $9.50
Company profile
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso No...
Show more
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 510 984 1761
- Website
- https://www.eksobionics.com
- Address
- 101 Glacier Point, Suite A, San Rafael, United States
Latest news
No headlines yet.
